How does Sitagliptin improve outcomes in patients with metabolic syndrome by addressing multiple risk factors, including insulin resistance and dyslipidemia?
Share
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Sitagliptin improve outcomes in patients with metabolic syndrome by addressing multiple risk factors, including insulin resistance and dyslipidemia?
Sitagliptin improves glycemic control by enhancing incretin hormones, which increase insulin release and decrease glucagon levels, helping to manage both insulin resistance and dyslipidemia in metabolic syndrome patients.